Elite in Esophageal Cancer

Gail E. Darling

200 Elizabeth St, M5G, 2C4, 
Toronto, ON, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Elite in Esophageal Cancer
200 Elizabeth St, M5G, 2C4, 
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Gail Darling practices in Toronto, Canada. Darling is rated as an Elite expert by MediFind in the treatment of Esophageal Cancer. Their top areas of expertise are Esophageal Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Lymphadenectomy.

Their clinical research consists of co-authoring 218 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 78 articles and participated in 5 clinical trials in the study of Esophageal Cancer.

Locations

200 Elizabeth St, M5G, 2C4, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Tissue Collection for Gastro-esophageal Cancer Primary Cell Line Establishment
Tissue Collection for Gastro-esophageal Cancer Primary Cell Line Establishment
Enrollment Status: Recruiting
Publish Date: May 14, 2025
Intervention Type: Other
PreOperative Treatment With chEmotheRapy or chemoRAdiatioN in esophaGeal or gastroEsophageal adenocaRcinoma
PreOperative Treatment With chEmotheRapy or chemoRAdiatioN in esophaGeal or gastroEsophageal adenocaRcinoma
Enrollment Status: Completed
Publish Date: August 28, 2024
Intervention Type: Drug, Other
Study Drug: (Epirubicin Cisplatin 5-Fluorouracil / Xeloda) OR 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel
Study Phase: Phase 2/Phase 3
Feasibility and Effectiveness of Prehabilitation in High-risk Surgical Patients
Feasibility and Effectiveness of Prehabilitation in High-risk Surgical Patients
Enrollment Status: Active_not_recruiting
Publish Date: May 08, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
The Utility of Circulating Tumour Cells and Plasma microRNA Detection to Predict the Response to Treatment in Patients With Esophageal Adenocarcinoma
The Utility of Circulating Tumour Cells and Plasma microRNA Detection to Predict the Response to Treatment in Patients With Esophageal Adenocarcinoma
Enrollment Status: Completed
Publish Date: March 08, 2024
Intervention Type: Other
The Contemporary Significance of Deep Venous Thrombosis and Pulmonary Embolus in Patients Undergoing Esophagectomy: A Pilot Study to Evaluate the Incidence of DVT and PE After Major Esophageal Resections
The Contemporary Significance of Deep Venous Thrombosis and Pulmonary Embolus in Patients Undergoing Esophagectomy: A Pilot Study to Evaluate the Incidence of DVT and PE After Major Esophageal Resections
Enrollment Status: Completed
Publish Date: February 24, 2021
A Randomized Controlled Feasibility Study Looking at Differences in Hospital Stay Variables Following Omission of Daily Routine Chest Radiographs After Pulmonary Resection.
A Randomized Controlled Feasibility Study Looking at Differences in Hospital Stay Variables Following Omission of Daily Routine Chest Radiographs After Pulmonary Resection.
Enrollment Status: Completed
Publish Date: May 01, 2020
Intervention Type: Diagnostic test
Study Phase: Phase 2
Assessment of Patient Frailty Prior to Thoracic Surgery: A Feasibility Study
Assessment of Patient Frailty Prior to Thoracic Surgery: A Feasibility Study
Enrollment Status: Completed
Publish Date: May 07, 2019
Intervention Type: Other
View 6 Less Clinical Trials

212 Total Publications

Surveillance frequency in resected esophageal cancer: Towards personalization of follow-up.
Surveillance frequency in resected esophageal cancer: Towards personalization of follow-up.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: February 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Darling's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile